Ubs Group Ag Eyenovia, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Eyenovia, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 1,708 shares of EYEN stock, worth $170. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,708

Previous 32,788 94.79%

Holding current value

$170

Previous $19,000 100.0%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.46 - $1.44 $14,296 - $44,755	-31,080 Reduced 94.79%	1,708 $0
Q2 2024 Aug 13, 2024	SELL	$0.52 - $1.06 $6,513 - $13,276	-12,525 Reduced 27.64%	32,788 $19,000
Q1 2024 May 13, 2024	BUY	$0.99 - $2.37 $3,808 - $9,117	3,847 Added 9.28%	45,313 $44,000
Q4 2023 Feb 09, 2024	BUY	$1.08 - $2.08 $26,981 - $51,964	24,983 Added 151.57%	41,466 $86,000
Q3 2023 Nov 09, 2023	SELL	$1.57 - $2.54 $3,454 - $5,588	-2,200 Reduced 11.78%	16,483 $27,000
Q2 2023 Aug 11, 2023	BUY	$2.21 - $5.75 $30,867 - $80,310	13,967 Added 296.16%	18,683 $44,000
Q1 2023 May 12, 2023	SELL	$1.72 - $3.53 $9,368 - $19,227	-5,447 Reduced 53.6%	4,716 $16,000
Q4 2022 Feb 08, 2023	BUY	$1.54 - $2.74 $13,341 - $23,736	8,663 Added 577.53%	10,163 $16,000
Q2 2022 Aug 10, 2022	SELL	$1.71 - $3.26 $4,984 - $9,502	-2,915 Reduced 66.02%	1,500 $3,000
Q1 2022 May 16, 2022	SELL	$2.66 - $3.99 $59,778 - $89,667	-22,473 Reduced 83.58%	4,415 $14,000
Q4 2021 Feb 14, 2022	BUY	$3.5 - $6.58 $72,758 - $136,785	20,788 Added 340.79%	26,888 $108,000
Q3 2021 Nov 15, 2021	SELL	$3.97 - $5.64 $5,164 - $7,337	-1,301 Reduced 17.58%	6,100 $30,000
Q2 2021 Aug 13, 2021	BUY	$4.36 - $5.75 $17,810 - $23,488	4,085 Added 123.19%	7,401 $37,000
Q1 2021 May 12, 2021	BUY	$5.11 - $7.41 $16,944 - $24,571	3,316 New	3,316 $17,000
Q4 2020 Feb 11, 2021	SELL	$3.11 - $6.06 $8,107 - $15,798	-2,607 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$2.61 - $5.1 $3,374 - $6,594	-1,293 Reduced 33.15%	2,607 $8,000
Q2 2020 Jul 31, 2020	BUY	$2.6 - $3.81 $6,975 - $10,222	2,683 Added 220.46%	3,900 $11,000
Q1 2020 May 01, 2020	BUY	$1.77 - $4.92 $2,154 - $5,987	1,217 New	1,217 $3,000
Q4 2019 Feb 14, 2020	SELL	$2.67 - $4.48 $6,709 - $11,258	-2,513 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.55 - $4.91 $10,263 - $19,762	-4,025 Reduced 61.56%	2,513 $9,000
Q2 2019 Aug 14, 2019	BUY	$4.08 - $6.87 $26,675 - $44,916	6,538 New	6,538 $28,000
Q1 2019 May 14, 2019	SELL	$2.63 - $6.3 $47,621 - $114,074	-18,107 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.6 - $4.24 $42,159 - $68,751	16,215 Added 857.03%	18,107 $52,000
Q3 2018 Nov 14, 2018	SELL	$4.02 - $7.22 $2,001 - $3,595	-498 Reduced 20.84%	1,892 $8,000
Q2 2018 Aug 14, 2018	BUY	$6.25 - $9.49 $10,393 - $15,781	1,663 Added 228.75%	2,390 $15,000
Q1 2018 May 15, 2018	BUY	$8.11 - $9.95 $5,895 - $7,233	727 New	727 $7,000

Others Institutions Holding EYEN

# of Institutions

Shares Held

13.4M

Call Options Held

13.1K

Put Options Held

21.3K

View Full List

About EYENOVIA, INC.

Ticker EYEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,212,900
Market Cap $3.42M
Description
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...

More about EYEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account